医学
替莫唑胺
耐火材料(行星科学)
系列(地层学)
垂体瘤
内科学
肿瘤科
放射治疗
生物
天体生物学
物理
古生物学
作者
Xiao-Hai Liu,Congxin Dai,Chuan Tian,Xinjie Bao,Kan Deng,Yong Yao,Yiguang Chen,Mingchu Li,Ge Chen,Ming Feng,Renzhi Wang
标识
DOI:10.1016/j.eprac.2024.10.008
摘要
The management of refractory pituitary adenomas (RPA) presents significant challenges. This study aimed to evaluate the long-term treatment outcomes of patients with RPA managed with temozolomide (TMZ) and to identify potential biomarkers for predicting TMZ treatment response.
科研通智能强力驱动
Strongly Powered by AbleSci AI